Regulation of Early Complement Component Expression

Agency: National Institute of Health (NIH)
Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 1R29AR043172-01A2
Application #: 2082808
Study Section: Allergy and Immunology Study Section (ALY)


NIH 2000 R29 AR	Regulation of Early Complement Component Expression Sullivan, Kathleen E. / Children's Hospital of Philadelphia	$132,295
NIH 1999 R29 AR	Regulation of Early Complement Component Expression Sullivan, Kathleen E. / Children's Hospital of Philadelphia
NIH 1998 R29 AR	Regulation of Early Complement Component Expression Sullivan, Kathleen E. / Children's Hospital of Philadelphia
NIH 1997 R29 AR	Regulation of Early Complement Component Expression Sullivan, Kathleen E. / Children's Hospital of Philadelphia
NIH 1996 R29 AR	Regulation of Early Complement Component Expression Sullivan, Kathleen E. / Children's Hospital of Philadelphia

Suriano, April R; Sanford, Amy N; Kim, Nahmah et al. (2005) GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol 25:9073-81